Effective today—Bright Minds Biosciences shares will commence trading on Nasdaq under the ticker symbol “DRUG.” Bright Minds is already listed on the Canadian Stock Exchange (CSE:DRUG) under the same symbol. Nasdaq Stock Market LLC approved the listing of the company’s common stock on The Nasdaq Capital Market. Bright Minds’... Read more
Caroline Pineau is more than just a cannabis entrepreneur based out of Haverhill, Massachusetts. She’s also an active part of the community, and strives to lift up other women and marginalized folks in her work. This is evidenced by her work joining forces with another business owner, Caroline Frankel, to... Read more
Headcount, a non-partisan organization that strives to get people registered to vote through music, has announced a new effort to legalize cannabis on a federal level and clear the records of thousands of people who have been convicted of cannabis-related crimes. On November 9, Headcount and the U.S. Cannabis... Read more
Eligible patients in South Dakota can officially file applications to receive a medical cannabis card under a new law that has had a clumsy rollout. A notice posted Monday on a state government website dedicated to the new medical cannabis program said that physicians “can now access the medical... Read more
A Texas judge has issued a temporary injunction blocking the state’s prohibition on Delta-8 THC, ruling that regulators may have acted improperly when they banned products containing the controversial cannabinoid. The ruling temporarily removes Delta-8 THC from Schedule I of the state’s list of controlled substances and allows retailers... Read more
urban-gro, Inc. Reports Record Third Quarter 2021 Financial Results and Raises Full Year 2021 Revenue Guidance Record third quarter revenue of $18.3 million, representing growth of 119% compared to the prior year period; organic revenue growth was 106%, excluding contribution from the 2WR+ acquisition Quarterly net income of $0.1... Read more
MedMen Reports 13% Year-over-Year Quarterly Revenue Growth and Fifth Consecutive Quarter of Positive Retail Adjusted EBITDA Q1 2022 Highlights First quarter revenue from continuing operations increased 13.4% year-over-year Total Retail Revenue including New York increased 17.6% year-over-year During the quarter, Company announced transformative capital raise and restructuring of senior... Read more
Aurora Cannabis Announces Fiscal 2022 First Quarter Results Transformation Plan On Track; Actions Taken-to-Date Have Driven Over $33 Million in Annualized Run-Rate Cost Savings Total Cannabis Net Revenue, Net of Provisions, Grew ~10% to $60.1 million Compared to $54.8 Million in Q4 2021 Adjusted EBITDA Excluding Restructuring Costs Improved... Read more
As we have written about before, the corporate practice of medicine doctrine (“CPOM”) is a creature of state law (click here to review a prior post on CPOM). While some states do not have a CPOM doctrine (like Florida), other states have very strict CPOM doctrines (like New York and California). At its core, CPOM
MINDCURE’s President and CEO, Kelsey Ramsden updates investors on iSTRYM’s launch and rapid penetration, as well as drug development news on several fronts.
